ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 734,75
0,01%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Eiger BioPharmaceuticals Inc (EIGR)

  7. Eiger BioPharmaceuticals Inc (EIGR) Actualités

EIGR

Eiger BioPharmaceuticals (EIGR)

Eiger BioPharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:EIGR
DateHeureSourceTitreSymboleSociété
01/04/202417h12GlobeNewswire Inc.Eiger BioPharmaceuticals Files for Voluntary Chapter 11 ProtectionNASDAQ:EIGREiger BioPharmaceuticals Inc
11/03/202421h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EIGREiger BioPharmaceuticals Inc
18/01/202423h49PR Newswire (US)Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in JapanNASDAQ:EIGREiger BioPharmaceuticals Inc
04/01/202414h00PR Newswire (US)Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock SplitNASDAQ:EIGREiger BioPharmaceuticals Inc
11/12/202322h01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:EIGREiger BioPharmaceuticals Inc
04/12/202312h01Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:EIGREiger BioPharmaceuticals Inc
01/12/202322h02Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:EIGREiger BioPharmaceuticals Inc
24/11/202312h01Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:EIGREiger BioPharmaceuticals Inc
09/11/202322h27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EIGREiger BioPharmaceuticals Inc
09/11/202322h05PR Newswire (US)Eiger BioPharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:EIGREiger BioPharmaceuticals Inc
03/11/202302h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EIGREiger BioPharmaceuticals Inc
30/10/202321h51Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EIGREiger BioPharmaceuticals Inc
28/09/202322h54Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EIGREiger BioPharmaceuticals Inc
12/09/202323h17Dow Jones NewsEiger BioPharmaceuticals to Discontinue Chronic Hepatitis Delta Study, Ends Licensing TalksNASDAQ:EIGREiger BioPharmaceuticals Inc
12/09/202322h05PR Newswire (US)Eiger to Discontinue Phase 3 LIMT-2 Trial of Peginterferon Lambda in Patients with Chronic Hepatitis DeltaNASDAQ:EIGREiger BioPharmaceuticals Inc
05/09/202322h05PR Newswire (US)Eiger BioPharmaceuticals to Present at H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:EIGREiger BioPharmaceuticals Inc
15/08/202312h00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:EIGREiger BioPharmaceuticals Inc
14/08/202322h05PR Newswire (US)Eiger BioPharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:EIGREiger BioPharmaceuticals Inc
29/06/202314h00PR Newswire (US)Eiger BioPharmaceuticals to Focus on Metabolic Diseases with Avexitide; David Apelian Takes Helm as CEONASDAQ:EIGREiger BioPharmaceuticals Inc
28/06/202322h05PR Newswire (US)Eiger BioPharmaceuticals to Host Business Update Call TomorrowNASDAQ:EIGREiger BioPharmaceuticals Inc
20/06/202312h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EIGREiger BioPharmaceuticals Inc
11/05/202322h17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EIGREiger BioPharmaceuticals Inc
11/05/202322h00PR Newswire (US)Eiger BioPharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:EIGREiger BioPharmaceuticals Inc
03/05/202322h05PR Newswire (US)Eiger BioPharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:EIGREiger BioPharmaceuticals Inc
26/04/202322h40Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:EIGREiger BioPharmaceuticals Inc
26/04/202322h39Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:EIGREiger BioPharmaceuticals Inc
26/04/202322h38Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:EIGREiger BioPharmaceuticals Inc
13/04/202314h00PR Newswire (US)Eiger BioPharmaceuticals Strengthens Management Team with New AppointmentsNASDAQ:EIGREiger BioPharmaceuticals Inc
10/04/202319h38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EIGREiger BioPharmaceuticals Inc
17/03/202321h12Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:EIGREiger BioPharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:EIGR

Dernières Valeurs Consultées

NASDAQ
MSFT
Microsoft
EU
ACA
Credit Agricole
EU
HO
Thales
NYSE
MRK
Merck
EU
DG
Vinci
EU
LR
Legrand
EU
MC
Lvmh Moet Hennessy Louis...
EU
EN
Bouygues
EU
AI
Air Liquide
EU
BEL20
Bel 20
EU
PX4
SBF 120
COIN
ETHUSD
Ethereum
EU
PX1
CAC 40
EU
ML
Michelin
EU
AF
Air FranceKLM
EU
CAP
Capgemini
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés